Hoffman, K
The mechanism works through appetite suppression, delayed gastric emptying, and improved insulin sensitivity
Use With Caution In Research Models Involving: Diabetes or impaired glucose regulation Insulin resistance or metabolic syndrome Cardiovascular disease or uncontrolled hypertension Fluid-retention susceptibility or fluid-balancerelated conditions Hormonal or endocrine disorders Sleep apnea or significant respiratory disorders Chronic migraines or neurological sensitivity Kidney or liver impairment Avoid or Carefully Evaluate in Research Models With: Active or suspected malignancies History of growth-sensitive tumors Severe uncontrolled endocrine disorders Severe uncontrolled cardiovascular disease Pregnancy or breastfeeding contexts Known hypersensitivity to peptide compounds Additional Research Considerations Because Ipamorelin may increase endogenous growth hormone and downstream IGF-1 activity, research involving abnormal cellular proliferation, tumor-growth pathways, or uncontrolled metabolic disease should be approached with particular caution
Ipamorelin is listed on the World Anti-Doping Agency (WADA) Prohibited List under the category of peptide hormones, growth factors, related substances, and mimetics
In most of these (n = 4) fake samples, we identified no API, whereas another contained methyltestosterone and stanozolol, the second contained tadalafil and sildenafil, and the third contained methandienone and sildenafil
